About Biobot Surgical Pte LtdBiobot Surgical is a Singapore-based medical technology company focused on developing advanced robotic solutions for prostate cancer diagnosis and treatment. Founded in 2007, the company operates at the intersection of robotics, medical imaging, and clinical applications to improve precision and outcomes in minimally invasive procedures.The company’s flagship platform, the iSR’obot™ Mona Lisa, is a robotic-assisted system designed for transperineal prostate biopsy and related procedures, with regulatory approvals in major global markets including the US, Europe, and Asia-Pacific.
About Biobot Surgical Pte LtdBiobot Surgical is a Singapore-based medical technology company focused on developing advanced robotic solutions for prostate cancer diagnosis and treatment. Founded in 2007, the company operates at the intersection of robotics, medical imaging, and clinical applications to improve precision and outcomes in minimally invasive procedures.The company’s flagship platform, the iSR’obot™ Mona Lisa, is a robotic-assisted system designed for transperineal prostate biopsy and related procedures, with regulatory approvals in major global markets including the US, Europe, and Asia-Pacific.
About Biobot Surgical Pte LtdBiobot Surgical is a Singapore-based medical technology company focused on developing advanced robotic solutions for prostate cancer diagnosis and treatment. Founded in 2007, the company operates at the intersection of robotics, medical imaging, and clinical applications to improve precision and outcomes in minimally invasive procedures.The company’s flagship platform, the iSR’obot™ Mona Lisa, is a robotic-assisted system designed for transperineal prostate biopsy and related procedures, with regulatory approvals in major global markets including the US, Europe, and Asia-Pacific.